Senores Pharmaceuticals Posts Robust Q1FY25-26 Results, Eyes 50% Revenue Growth
Moneylife Digital Team 30 July 2025
Senores Pharmaceuticals Limited (Senores), a research-driven pharmaceuticals company specialising in generic products, reported a stellar performance for Q1FY25-26, with revenue surging 72%...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Get access to complete archives
Rs 5000 + GST
 
 
Already a subscriber ? Log in
Free Helpline
Legal Credit
Feedback